Pacira BioSciences Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for Pacira BioSciences stock have an average target of 30.25, with a low estimate of 25 and a high estimate of 38. The average target predicts an increase of 19.05% from the current stock price of 25.41.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$25	$30.25	$30	$38
Change	-1.61%	+19.05%	+18.06%	+49.55%

* Price targets were last updated on Mar 26, 2026.

Analyst Ratings

The average analyst rating for Pacira BioSciences stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	4	4	4	4	4	3
Buy	1	1	1	1	0	0
Hold	1	2	2	2	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	7	7	7	5	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Glen Santangelo Barclays	Barclays	Hold Maintains $27 → $25	Hold	Maintains	$27 → $25	-1.61%	Mar 26, 2026
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $38	Strong Buy	Reiterates	$38	+49.55%	Jan 9, 2026
Serge Belanger Needham	Needham	Strong Buy Maintains $30	Strong Buy	Maintains	$30	+18.06%	Jan 9, 2026
Glen Santangelo Barclays	Barclays	Hold Initiates $27	Hold	Initiates	$27	+6.26%	Dec 9, 2025
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $38	Strong Buy	Initiates	$38	+49.55%	Nov 17, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

775.69M

from 726.41M

6.78%

from 726.41M

Revenue Next Year

841.95M

from 775.69M

8.54%

from 775.69M

EPS This Year

2.70

from 0.16

1,611.28%

from 0.16

EPS Next Year

3.56

from 2.70

31.93%

from 2.70

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	541.53M	666.82M	674.98M	700.97M	726.41M	775.69M	841.95M
Revenue Growth	26.04%	23.14%	1.22%	3.85%	3.63%	6.78%	8.54%
EPS	0.92	0.34	0.89	-2.15	0.16	2.70	3.56
EPS Growth	-72.37%	-63.04%	160.68%	-	-	1,611.28%	31.93%
Forward PE	-	-	-	-	-	9.41	7.13
No. Analysts	-	-	-	-	-	9	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	807.1M	910.0M
Avg	775.7M	842.0M
Low	736.0M	777.1M

Revenue Growth

Revenue Growth	2026	2027
High	11.1%	17.3%
Avg	6.8%	8.5%
Low	1.3%	0.2%

EPS Forecast

EPS	2026	2027
High	3.20	4.10
Avg	2.70	3.56
Low	2.38	3.04

EPS Growth

EPS Growth	2026	2027
High	1,929.0%	51.6%
Avg	1,611.3%	31.9%
Low	1,408.8%	12.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.